These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9843903)
1. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME. Broere A; Van Den Meiracker AH; Boomsma F; Derkx FH; Veld AJ; Schalekamp MA Am J Physiol; 1998 Dec; 275(6):F870-7. PubMed ID: 9843903 [TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects. van der Linde NA; van den Meiracker AH; Boomsma F J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265 [TBL] [Abstract][Full Text] [Related]
5. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans. Bech JN; Nielsen CB; Pedersen EB Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847 [TBL] [Abstract][Full Text] [Related]
6. Effects of L-arginine and L-NAME on the renal function in hypertensive and normotensive subjects. van den Meiracker AH; van der Linde NA; Broere A; Derkx FH; Boomsma F Nephron; 2002 Jul; 91(3):444-51. PubMed ID: 12119475 [TBL] [Abstract][Full Text] [Related]
7. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes. Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism. van der Linde NA; Boomsma F; van den Meiracker AH J Hypertens; 2005 May; 23(5):1017-24. PubMed ID: 15834288 [TBL] [Abstract][Full Text] [Related]
10. Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice. Shahid M; Francis J; Matrougui K; Majid DS Am J Physiol Renal Physiol; 2010 Jul; 299(1):F217-24. PubMed ID: 20410217 [TBL] [Abstract][Full Text] [Related]
11. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study. Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658 [TBL] [Abstract][Full Text] [Related]
12. The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Venkatakrishnan U; Chen C; Lokhandwala MF Clin Exp Hypertens; 2000 Apr; 22(3):309-24. PubMed ID: 10803736 [TBL] [Abstract][Full Text] [Related]
13. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. Boffa JJ; Arendshorst WJ J Am Soc Nephrol; 2005 Jan; 16(1):117-24. PubMed ID: 15563566 [TBL] [Abstract][Full Text] [Related]
14. Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension. Krier JD; Romero JC Am J Physiol; 1998 Jan; 274(1):R175-80. PubMed ID: 9458915 [TBL] [Abstract][Full Text] [Related]
15. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Sigmon DH; Beierwaltes WH Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236 [TBL] [Abstract][Full Text] [Related]